SCHEMBL14067490

SCHEMBL14067490

Cc1cn2cc(-c3ccc(N(C)C)cc3)nc2c(C)n1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APP P05067 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22307609 0.81 ADORA1 (0.57)
SCHEMBL14076031 0.76 APP (0.74) APP
SCHEMBL14067489 0.73 APP (0.58) APP
SCHEMBL14076014 0.72 APP (1.00) APP
SCHEMBL24163735 0.72 ALDH1A1 (0.33)
SCHEMBL12961109 0.71 HRH3 (0.55) APP
SCHEMBL14067494 0.71 APP (0.47) APP
SCHEMBL17626879 0.70 APP (0.58) APP
SCHEMBL1080521 0.69 APP (0.49) APP
SCHEMBL13290926 0.69 APP (0.72) APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080219922-A1 Alzheimer's Disease Imaging Agents EMORY UNIVERSITY 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219922-A1 Alzheimer's Disease Imaging Agents APP, PSEN1, MAPT APP 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.